Immuneering (IMRX) Assets Average (2021 - 2026)

Immuneering's Assets Average history runs 6 years deep, the most recent figure standing at $223.4 million for Q1 2026.

• In Q1 2026, Assets Average rose 332.12% year-over-year to $223.4 million; the TTM figure through Mar 2026 stood at $223.4 million (up 332.12% YoY), while the FY2025 annual figure was $142.3 million, up 83.32% from the prior year.
• Assets Average was $223.4 million for Q1 2026 at Immuneering, down from $236.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $236.5 million in Q4 2025 to a low of $45.4 million in Q2 2025.
• Historically, Assets Average has averaged $120.0 million across 5 years, with a median of $116.3 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Assets Average tumbled 45.74% in 2025, then surged 332.12% in 2026.
• A 5-year view of Assets Average shows it stood at $128.0 million in 2022, then dropped by 15.46% to $108.2 million in 2023, then plunged by 43.98% to $60.6 million in 2024, then soared by 290.07% to $236.5 million in 2025, then dropped by 5.55% to $223.4 million in 2026.
• The last three Assets Average figures came in at $223.4 million (Q1 2026), $236.5 million (Q4 2025), and $140.6 million (Q3 2025), per Business Quant data.